Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AmdocsFRA:AOS +2.09%76 3-Year EPS without NRI Growth Rate is 9.70% as of Jun. 2026, which is 2% below its 10-year median of 9.85. GuruFocus rates FRA:AOS with a GF Score™ of 76/100 and a GF Value™ of €76.12 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 2,064 Software companies, Amdocs ranks worse than 54.12% on this metric.
During the past 12 months, Amdocs's average EPS without NRI Growth Rate was 18.00% per year.
During the past 3 years, the average EPS without NRI Growth Rate was 9.70% per year.
During the past 5 years, the average EPS without NRI Growth Rate was 9.70% per year.
During the past 10 years, the average EPS without NRI Growth Rate was 7.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Amdocs was 133.40% per year. The lowest was -39.00% per year. And the median was 9.85% per year.
Amdocs (FRA:AOS) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Amdocs 3-Year EPS without NRI Growth Rate Related Terms
FRA:AOS vs MBGL, QLYS, WEX: 3-Year EPS without NRI Growth Rate Comparison
For the Software - Infrastructure subindustry, Amdocs's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amdocs 3-Year EPS without NRI Growth Rate vs Software Industry
For the Software industry and Technology sector, Amdocs's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Amdocs's 3-Year EPS without NRI Growth Rate falls into.
Amdocs 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 9.70% mean?
Amdocs (FRA:AOS) has a 3-Year EPS without NRI Growth Rate of 9.70% as of Jun. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Amdocs and its competitors. This is near median its historical median of 9.85. According to the industry distribution chart, Amdocs ranks #1117 out of 2064 companies in the Software industry, placing it in the top 54.1%.
Is Amdocs' 3-Year EPS without NRI Growth Rate too high?
Amdocs' current 3-Year EPS without NRI Growth Rate of 9.70% is near median its 10-year median of 9.85. The Software industry median 3-Year EPS without NRI Growth Rate is 12.40. Amdocs' value of 9.70% is 21.8% below this industry median. Based on the distribution chart, Amdocs ranks #1117 out of 2064 companies in the Software industry, which is below the industry midpoint. Overall, Amdocs has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Amdocs' 3-Year EPS without NRI Growth Rate compare to MBGL and QLYS?
According to the Software industry distribution chart, Amdocs ranks #1117 out of 2064 companies for 3-Year EPS without NRI Growth Rate. This places Amdocs in the lower half of its industry. The industry median 3-Year EPS without NRI Growth Rate is 12.40. Amdocs' value of 9.70% is 21.8% below this benchmark. While the company's 10-year median is 9.85 vs. the industry median of 12.40, Amdocs has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Software company?
The median 3-Year EPS without NRI Growth Rate among Software companies is 12.40, based on 2,064 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Amdocs's current 3-Year EPS without NRI Growth Rate of 9.70% is 21.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Amdocs and its competitors. For the Software industry, the median 3-Year EPS without NRI Growth Rate is 12.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amdocs's current 3-Year EPS without NRI Growth Rate is 9.70%, which is near median its own 10-year median of 9.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amdocs stock overvalued right now?
Based on GuruFocus' analysis, Amdocs (FRA:AOS) is currently considered Significantly Undervalued. The stock's GF Value™ is €76.12, compared to a current price of €52.86 — trading 30.6% below its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 9.70%, which is near median its 10-year median of 9.85 and 21.8% below the Software industry median of 12.40. Amdocs' overall GF Score™ is 76/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Amdocs (FRA:AOS), the current 3-Year EPS without NRI Growth Rate is 9.70% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Amdocs (FRA:AOS) Overvalued in 2026?
Based on GuruFocus' analysis, Amdocs stock appears to be undervalued.
The current stock price of €52.86 is trading 30.6% below its estimated GF Value™ of €76.12.
GuruFocus considers Amdocs to be Significantly Undervalued.
Key valuation signals for FRA:AOS:
3-Year EPS without NRI Growth Rate: 9.70% (near median its 10-year median of 9.85)
GF Value™: €76.12 vs. price of €52.86 (30.6% below fair value)
Industry Position: 21.8% below the Software median (#1117 of 2064)
No single metric tells the full story. See the FRA:AOS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Amdocs Ltd is a provider of software and services to communications, entertainment, and media service providers. The Company operates in a single segment and designs, develops, markets, supports, implements, and operates open and modular cloud offerings. Its portfolio includes solutions across digital business systems and legacy business and operational support systems, supporting multiple lines of business such as wireless, broadband, cable, fiber, satellite, and digital services. The Company leverages artificial intelligence to support digital transformation, cloud adoption, and intelligent network automation. Geographically, it derives a majority of its revenue from North America and also operates in Europe and the rest of the world.
76GF Score
Get the complete analysis for FRA:AOS
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:AOS has been successfully added to your 
